Pete Pete
Source health

section

Finance

Markets, money, and the business of the world. Read-only — these stories don't post to Matrix.

375 stories archived

Intel Bets on Cheaper AI as Foundry Losses Mount
MarketBeat Oct 14 · 6 min read

Intel Bets on Cheaper AI as Foundry Losses Mount

Intel unveiled its Crescent Island GPU D-Series for budget inference computing as its foundry unit posts losses, insiders buy shares, and short interest climbs ahead of Q3 earnings.

Don’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could Deepen
MarketBeat Oct 14 · 4 min read

Don’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could Deepen

NVIDIA is reportedly in early talks to acquire open-weight AI startup Reflection AI, a move analysts view as deepening its hardware moat rather than shifting strategy, ahead of late-November earnings.

The Social Security COLA for 2027 Will Be Largest since 2023
Wolf Street Oct 14 · 3 min read

The Social Security COLA for 2027 Will Be Largest since 2023

The numbers are out for the Cost-of-Living Adjustments for Old-Age, Survivors, and Disability Insurance and Supplemental Security Income.

Birkenstock's Strong Growth Creates a Buying Opportunity
MarketBeat Oct 14 · 5 min read

Birkenstock's Strong Growth Creates a Buying Opportunity

Birkenstock raised its fiscal 2026 outlook after strong revenue and earnings growth, but tariffs, currency pressures, and rising inventory have kept BIRK stock near its 52-week low.

High Voltage Returns: Navitas Rewires AI Data Centers
MarketBeat Oct 14 · 7 min read

High Voltage Returns: Navitas Rewires AI Data Centers

Navitas Semiconductor unveiled a 24-kilowatt power delivery board with NVIDIA for AI data centers, as investors weigh its consumer electronics pivot against growing enterprise demand and high short interest.

Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
MarketBeat Oct 14 · 5 min read

Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built

Biotech stocks trade on FDA trial phases. Phase 2 data often builds value, cash runway limits dilution, and Quantum BioPharma just began a phase 2 MS trial.

Albertsons Is Betting on a Turnaround—But Will It Pay Off?
MarketBeat Oct 14 · 5 min read

Albertsons Is Betting on a Turnaround—But Will It Pay Off?

Albertsons shares rose after Q2 FY2027 results as the company withdrew guidance, launched a business review, and advanced its ACI Edge turnaround plan amid mixed margins and analyst caution.

Venezuela's Oil Revival Is Gaining Momentum—3 Energy Stocks Positioned to Benefit
MarketBeat Oct 14 · 5 min read

Venezuela's Oil Revival Is Gaining Momentum—3 Energy Stocks Positioned to Benefit

Chevron, BP and Halliburton are investing billions to revive Venezuela's oil and gas industry as the U.S. looks to offset supply disruptions from the Strait of Hormuz.

PepsiCo's Earnings Beat Masks a Bigger Problem With Its North American Business
MarketBeat Oct 14 · 4 min read

PepsiCo's Earnings Beat Masks a Bigger Problem With Its North American Business

PepsiCo topped Q3 2026 revenue and EPS estimates but cut its full-year growth guidance amid weak North American volumes, trading near 16x earnings with a 4.67% dividend yield.

Tax Credit Turmoil: Why Enphase and SolarEdge Face a Tough Road
MarketBeat Oct 14 · 5 min read

Tax Credit Turmoil: Why Enphase and SolarEdge Face a Tough Road

Enphase Energy and SolarEdge face sharp demand drops after the 30% solar tax credit's early expiration, but their earnings reveal different causes: a policy hangover versus an overpriced rally.

Sales of Existing Single-Family Homes Scrape along Bottom of 4-Year Dumpster, Supply at 11-Year High. Condo Sales at Record Low, Supply at Record High
Wolf Street Oct 13 · 5 min read

Sales of Existing Single-Family Homes Scrape along Bottom of 4-Year Dumpster, Supply at 11-Year High. Condo Sales at Record Low, Supply at Record High

Affordability crisis has softened in markets where home prices have fallen for a few years and hourly earnings have risen, but has worsened in others.

A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
MarketBeat Oct 13 · 6 min read

A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?

Micron shares fell on Chinese memory competition and labor concerns, yet strong earnings, secured 2027 orders and a $35 billion buyback suggest the pullback may be overdone.

Could T-Mobile's Satellite Competition Fears Create a Buying Opportunity?
MarketBeat Oct 13 · 6 min read

Could T-Mobile's Satellite Competition Fears Create a Buying Opportunity?

T-Mobile shares hit a 52-week low after SpaceX's spectrum deal sparked satellite-disruption fears, but strong earnings, cash flow, and a Raymond James upgrade suggest the sell-off was overdone.

Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runway
MarketBeat Oct 13 · 5 min read

Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runway

Johnson & Johnson posted Q3 revenue growth of 5.9% to $25.4 billion, raised guidance, and gained analyst support as its OTTAVA surgical system and talc settlement shape its long-term outlook.

Tesla's Robotaxi Lands in Paris—But Europe's Real Fight Is Over Cheap EVs
MarketBeat Oct 13 · 5 min read

Tesla's Robotaxi Lands in Paris—But Europe's Real Fight Is Over Cheap EVs

At the Paris Motor Show, Tesla debuts its Cybercab and FSD tech in Europe while Stellantis, Renault's Dacia, and BYD showcase affordable EVs, competing on pricing, incentives, and autonomous driving.

IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?
MarketBeat Oct 13 · 6 min read

IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?

IonQ shares fell about 9% after it agreed to acquire cybersecurity firm Elisity for roughly $1.3 billion in an all-stock deal, as it expands into post-quantum enterprise security.

JPMorgan Earnings Miss Estimates But Reveal Broad-Based Strength
MarketBeat Oct 13 · 5 min read

JPMorgan Earnings Miss Estimates But Reveal Broad-Based Strength

JPMorgan's Q3 revenue rose 8.1% to $50.9 billion with broad-based loan and deposit growth, but adjusted earnings missed estimates amid an investment banking slowdown and reduced buybacks.

Flex's AI Infrastructure Spin-Off Could Unlock Hidden Value
MarketBeat Oct 13 · 6 min read

Flex's AI Infrastructure Spin-Off Could Unlock Hidden Value

Flex launches modular Axiom AI data center racks ahead of its planned 2027 Axiom Solutions International spin-off, a move designed to separate high-margin AI infrastructure from its legacy manufacturing business.

A Silent Winner: Texas Instruments Anchors the AI Supercycle
MarketBeat Oct 13 · 6 min read

A Silent Winner: Texas Instruments Anchors the AI Supercycle

Texas Instruments launched new power management and telemetry chips for AI data centers, positioning its analog business as a dividend-paying infrastructure play ahead of Q3 earnings on Oct. 21.

Enlisting Capital: Wolfspeed's Defense Deal
MarketBeat Oct 13 · 6 min read

Enlisting Capital: Wolfspeed's Defense Deal

Wolfspeed secured a conditional $1.5 billion, 30-year Defense Department loan involving equity warrants and parallel funding terms, aimed at refinancing debt and scaling its Siler City silicon carbide plant.

Amazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?
MarketBeat Oct 13 · 1 min read

Amazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?

Amazon heads into Q3 earnings with AWS growth strong but $220 billion in AI spending and a reported Decart acquisition talk raising questions about returns, margins, and cash flow.

Ag Equipment’s Recovery Trade Meets Washington’s Scrutiny
MarketBeat Oct 13 · 5 min read

Ag Equipment’s Recovery Trade Meets Washington’s Scrutiny

An FTC-USDA inquiry into agricultural equipment competition sent Deere, AGCO, CNH Industrial, and Caterpillar shares lower, with the public comment period open through Dec. 7, 2026.

The Pentagon's $350 Million Quantum Push: Why IonQ Could Benefit More Than D-Wave
MarketBeat Oct 13 · 5 min read

The Pentagon's $350 Million Quantum Push: Why IonQ Could Benefit More Than D-Wave

The Defense Department pledged about $350 million for quantum computing, with IonQ and DARPA's Quantum Benchmarking Initiative emerging as key beneficiaries, though revenue impact remains uncertain.

Delta's Guidance Cut Could Spell Trouble for the Airline Industry
MarketBeat Oct 13 · 5 min read

Delta's Guidance Cut Could Spell Trouble for the Airline Industry

Delta cut its full-year profit guidance on high fuel costs, raising questions about whether United and Southwest will face similar pressure when they report earnings.